GlobeNewswire

Cisco Doubles Down on Security Innovation and Investment to Protect the Endpoint and Email

Dela

Cisco Introduces New Email Security Services to More Effectively Prevent Phishing and Spoofing Attacks

 

SAN FRANCISCO, April 16, 2018 (GLOBE NEWSWIRE) -- RSA - Employees remain an organization's greatest asset however they can be a risk when it comes to cybersecurity. Attackers are crafting highly targeted, fraudulent emails that look legitimate and use them to deliver malware to unsuspecting users. When successful, it costs the majority of companies $500K or more in lost revenue, customers, opportunities, and out-of-pocket costs.1 To combat the rise of advanced threats targeting employees, Cisco is announcing new email security services to protect users from these fraudulent emails, as well as new capabilities to protect employees' devices from ransomware, cryptomining, and fileless malware.

Nearly all endpoint security solutions on the market claim to block 99 percent of malware. But what about the one percent of threats that evade detection using sophisticated techniques? Cisco® Advanced Malware Protection (AMP) for Endpoints, a cloud-managed endpoint security solution, prevents attacks and helps uncover the one percent of threats that can cripple a business. Cisco is adding a number of new capabilities to AMP for Endpoints, including:

  • Sophisticated detection and protection mechanisms to stop today's threats, including ransomware, and cryptomining: Cisco is now bolstering its threat protection even when a user is offline. The new AMP for Endpoints exploit prevention helps protect against fileless attacks, including those that reside solely in memory. Cisco AMP's new malicious activity protection stops ransomware execution, killing the processes and preventing propagation.
    • Cisco threat researchers analyzed ransomware variants to identify the common techniques used for encryption. The result: a new engine that continuously protects against ransomware encryption and propagation to keep businesses safe from ransomware.
    • Fileless malware has recently gained popularity in part because of the difficulty in detecting it. Built directly into the foundation of Cisco AMP is a new protection mechanism that requires no tuning or adjustments to stop these threats. It protects against unpatched software vulnerabilities and keeps working around the clock, even when users are offline. 
       
  • Threat investigation with Cisco Visibility, a new cloud application built into the endpoint console which simplifies and accelerates security investigations so security analysts can rapidly investigate incidents with confidence, quickly and at scale. It ingests, normalizes, and enriches security events and provides a visual representation of the extent of a compromise spanning from endpoints to network to cloud.
    • Cisco Visibility combines threat intelligence from Cisco Talos(TM) and third parties with internal security event and alert data from across an organization's security infrastructure to simplify investigations, reduce complexity, and shorten incident triage and remediation time.
    • Visibility minimizes the need to switch between multiple consoles to perform common tasks. With a few simple clicks, a user can dive deeper into the data from Talos, Cisco Umbrella Investigate(TM), Threat Grid, AMP, and other sources to quickly understand how observables exist in an environment and how they relate to each other.

Cisco invests in new email security services 
No matter how much the threat landscape changes, malicious email and spam remain vital tools for adversaries to distribute malware, and many of these threats reach the endpoint. Organizations must protect their own company domains from being misused as the delivery mechanism of malicious emails, as well as protect their internal users from phishing and spoofing attacks from emails with suspect senders.

Cisco is helping address these issues and more effectively prevent email identity deception used in phishing attacks. Cisco has concluded an OEM agreement with Agari to market and sell new services that enhance its Email Security product. The new email security services introduced include:

  • Cisco Domain Protection: Automates the process of using email authentication to prevent phishing, protect brands from fraud, and maintain email governance by analyzing, updating, and taking action against senders misusing their domain to send malicious email. This service uses Domain-Based Message Authentication, Reporting, and Conformance (DMARC), an email authentication standard, and real-time reporting back to domain users about noncompliant emails being sent from their domains. This will be a requirement for many organizations in the future, and as of October 2017, the U.S. Department of Homeland Security ordered federal agencies with .gov email domains to fully implement strict DMARC policies by October 2018.
  • Cisco Advanced Phishing Protection: Adds sophisticated machine learning capabilities to Cisco Email Security to block advanced identity deception attacks for inbound email by assessing its threat posture. It also uses both global and local telemetry data combined with analytics and modeling to validate the reputation and authenticity of senders. This helps organizations understand which emails carry targeted phishing and business email compromise (BEC) attacks so only legitimate emails reach an employee inbox.

Deployment through managed security services
To enable customers of all sizes to realize the benefits of these new capabilities, Cisco is expanding its relationship with ConnectWise so managed service providers (MSP) can offer Cisco Security as a part of their portfolio. The expanded relationship will offer the new ConnectWise Advanced Security Dashboard. This cloud management platform fully integrates with the ConnectWise Manage business management solution and complements ConnectWise Unite with Cisco, the existing portal for MSPs based on leading Cisco cloud-managed products. The new ConnectWise Advanced Security Dashboard provides MSPs with the ability to deliver managed security services with Cisco's security portfolio including Cisco AMP for Endpoints,  Cisco Umbrella, Cisco Stealthwatch® Cloud, Cisco Adaptive Security Appliances, Cisco Next-Generation Firewall, and Cisco Meraki® MX appliances.

"Cisco understands that protecting employees and their endpoints requires more than just antivirus. Attackers leverage the Internet, email, and the network as vectors for breaching the endpoint," said Jeff Reed, Senior Vice President of Product for Cisco's Security Business Group. "We deliver greater employee protection using cloud-delivered defense against threats hosted on the Internet. Cisco is also now one of the few organizations paving the way toward eliminating email identity deception. Through our expanded partnership, investments, and technology innovations, we are committed to delivering to our customers the best email and endpoint protection."

Supporting Resources:

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company. 

_________________________
1 Cisco Annual Cybersecurity Report 2018.

Press Relations 
Raquel Prieto 
408-527-3754 
raqpriet@cisco.com 

Analyst Relations
Jenna Duston 
408-424 7210 
jeabeyta@cisco.com 

Investor Relations
Marty Palka 
408-526 6635
mpalka@cisco.com 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum